コンパニオンアニマル診断薬市場規模、シェア、成長分析、技術別、動物タイプ別、用途別、エンドユーザー別、地域別 - 産業別予測、2024～2031年

コンパニオンアニマル診断薬の世界市場規模は2022年に23億米ドルと評価され、2023年の25億3,000万米ドルから2031年には53億4,000万米ドルに成長し、予測期間（2024-2031年）のCAGRは9.8％で成長する見通しです。

ペットの慢性疾患の有病率の高まりと診断の進歩が、コンパニオンアニマル診断薬市場の大きな成長を促進する見通しです。2012年から2022年にかけて、イヌの糖尿病は40％、ネコの糖尿病は30％増加するという報告もあり、効果的な診断が急務となっています。ペットを飼う人の増加はこの市場をさらに後押ししており、少なくとも1匹の犬を飼っている世帯は6,390万世帯を超え、猫を飼っている世帯は約5,200万世帯に達しています。さらに、自動化・半自動化された診断検査の需要が急増し、サンプルの取り扱いの効率化が進んでいます。Point of Care Diagnostics（POCD）のような技術革新は迅速な結果を約束し、獣医学的サービスの向上を目指す政府のイニシアチブは長期的な市場拡大を支えます。米国の動物医療費は2031年までに330億米ドルに達すると予想されています。

目次

イントロダクション

• 調査の目的
• 調査範囲
• 定義

調査手法

• 情報調達
• 二次データと一次データの方法
• 市場規模予測
• 市場の前提条件と制限

エグゼクティブサマリー

• 世界市場の見通し
• 供給と需要の動向分析
• セグメント別機会分析

市場力学と見通し

• 市場概要
• 市場規模
• 市場力学
  • 促進要因と機会
  • 抑制要因と課題
• ポーター分析と影響
  • 競争企業間の敵対関係
  • 代替品の脅威
  • 買い手の交渉力
  • 新規参入業者の脅威
  • 供給企業の交渉力

主な市場の考察

• 重要成功要因
• 競合の程度
• 主な投資機会
• 市場エコシステム
• 市場の魅力指数（2023年）
• PESTEL分析
• マクロ経済指標
• バリューチェーン分析
• 価格分析
• 技術の進歩
• 規制情勢
• ケーススタディ

コンパニオンアニマル診断薬市場規模：技術別

• 市場概要
• 臨床生化学
  • 臨床化学分析
  • 試薬クリップカートリッジ
  • アナライザー
  • 血糖モニタリング
  • 血糖値試験紙
  • 血糖値モニター
  • 尿糖試験紙
  • 血液ガス電解質分析
  • 試薬クリップカートリッジ
  • 血液ガス・電解質分析装置
• 免疫診断
  • ラテラルフローアッセイ
  • 迅速検査
  • ストリップリーダー（ラテラルフローリーダー）
  • エリサ検査
  • アレルゲン特異的免疫診断検査
  • 免疫測定分析装置
  • その他の免疫診断動物の種類
• 血液学
  • カートリッジ
  • アナライザー
• 尿検査
  • クリップとカートリッジ/パネル
  • 尿分析装置
  • 尿検査ストリップ
• 分子診断
  • ポリメラーゼ連鎖反応検査
  • マイクロアレイ
  • その他の分子診断動物種
• その他のペット診断技術

コンパニオンアニマル診断薬市場規模：動物タイプ別

• 市場概要
• 犬
• 猫
• 馬
• その他のペット

コンパニオンアニマル診断薬市場規模：用途別

• 市場概要
• 臨床病理学
• 細菌学
• ウイルス学
• 寄生虫学
• その他の用途

コンパニオンアニマル診断薬市場規模：エンドユーザー別

• 市場概要
• 診断検査室
• 動物病院・クリニック
• 調査機関および大学
• 在宅ケアの設定

コンパニオンアニマル診断薬市場規模：地域別

• 北米
  • 米国
  • カナダ
• 欧州
  • 英国
  • ドイツ
  • スペイン
  • フランス
  • イタリア
  • その他欧州地域
• アジア太平洋地域
  • 中国
  • インド
  • 日本
  • 韓国
  • その他アジア太平洋地域
• ラテンアメリカ
  • ブラジル
  • その他ラテンアメリカ地域
• 中東・アフリカ
  • GCC諸国
  • 南アフリカ
  • その他中東・アフリカ

競合情報

• 上位5社の比較
• 主要企業の市場ポジショニング（2023年）
• 主な市場企業が採用した戦略
• 市場の最近の動向
• 企業の市場シェア分析（2023年）
• 主要企業の企業プロファイル
  • 会社概要
  • 製品ポートフォリオ分析
  • セグメント別シェア分析
  • 収益の前年比比較（2021-2023）

主要企業プロファイル

• Idexx Laboratories, Inc.
• Zoetis Inc.
• Thermo Fisher Scientific Inc.
• Biomerieux SA
• Virbac
• Neogen Corporation
• Fujifilm Holdings Corporation
• Indical Bioscience GmbH
• Idvet
• Randox Laboratories, Ltd.
• Bionote, Inc.
• Skyla Corporation
• Urit Medical Electronic Co., Ltd.
• Nova Biomedical
• Fassisi GmbH
• Swissavans AG
• Alvedia
• Megacor Veterinary Diagnostics
• Biopanda Reagents Ltd
• Anipoc Ltd
• Ring Biotechnology Co Ltd.

結論と推奨事項

Global Companion Animal Diagnostics Market size was valued at USD 2.3 billion in 2022 and is poised to grow from USD 2.53 billion in 2023 to USD 5.34 billion by 2031, growing at a CAGR of 9.8% during the forecast period (2024-2031).

The growing prevalence of chronic disorders in pets, coupled with advancements in diagnostics, is poised to drive significant growth in the companion animal diagnostics market. Reports indicate a staggering 40% rise in canine diabetes and a 30% increase in feline diabetes from 2012 to 2022, reflecting an urgent need for effective diagnostics. The rising number of pet owners further supports this market, with over 63.9 million households owning at least one dog and around 52 million with cats. Additionally, the demand for automated and semi-automated diagnostic testing is surging, enhancing efficiency in sample handling. Innovations such as Point of Care Diagnostics (POCD) promise expedited results, while government initiatives aimed at improving veterinary services underpin long-term market expansion. The U.S. veterinary care expenditure is expected to reach USD 33 billion by 2031.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Companion Animal Diagnostics market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Companion Animal Diagnostics Market Segmental Analysis

Global Companion Animal Diagnostics Market is segmented by Technology, Animal Type, Application, End User, and region. Based on Technology, the market is segmented into Clinical biochemistry, Immunodiagnostics, Hematology, Urinalysis, Molecularity Molecular diagnostics, and Other Companion Animal Diagnostic Technologies. Based on Animal Type, the market is segmented into Dogs, Cats, Horses, and Other companion animals. Based on Application, the market is segmented into Clinical Pathology, Bacteriology, Virology, Parasitology, and Other Applications. Based on End User, the market is segmented into Diagnostic Laboratories, Veterinary Hospitals & Clinics, Research Institutes & Universities, and Home-care Settings. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Companion Animal Diagnostics Market

The Global Companion Animal Diagnostics market is witnessing significant growth driven by the increasing demand for rapid testing and portable diagnostic tools designed for point-of-care (PoC) services. These tools have become essential for veterinarians, facilitating the quick detection of animal illnesses, particularly in remote locations like homes or shelters, and during emergencies. Major manufacturers are focusing on developing innovative portable diagnostics that enhance workflow in veterinary hospitals and research institutions. Additionally, pet healthcare spending, including veterinary treatments and pet insurance, has surged, encouraging pet owners, especially in North America and Europe, to invest in comprehensive care for their animals. This surge in demand for efficient, cost-effective diagnostic solutions underpins the expansion of the market.

Restraints in the Global Companion Animal Diagnostics Market

The growth of the Global Companion Animal Diagnostics market may be hindered by escalating pet care expenses, particularly in developing nations where there is a shortage of veterinarians. These rising costs could deter pet owners from seeking necessary diagnostic services, ultimately impacting market expansion. Additionally, a general lack of awareness regarding animal healthcare poses a substantial challenge, preventing pet owners from recognizing the importance of regular diagnostics. Collectively, these factors will likely create significant obstacles for the companion animal diagnostics market during the projected period, impeding its potential for growth and advancement.

Market Trends of the Global Companion Animal Diagnostics Market

The Global Companion Animal Diagnostics market is witnessing a significant trend driven by heightened research and development efforts focused on the diagnostic capabilities for companion animals, especially in relation to SARS-CoV-2 exposure. As various animal species emerge as potential vectors for COVID-19, key health organizations, including the CDC and USDA, are actively engaging in monitoring and studying these vulnerabilities. This surge in research not only enhances understanding of the epidemiological impact on animal and human health but also stimulates innovation in diagnostic devices. Consequently, the market is anticipated to expand, reflecting an increased demand for advanced diagnostic solutions that ensure better health outcomes for companion animals.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Driver & Opportunities
  • Restraints & Challenges
• Porters Analysis & Impact
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2023
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Technological Advancement
• Regulatory Landscape
• Case Studies

Global Companion Animal Diagnostics Market Size by Type & CAGR (2024-2031)

• Market Overview
• Clinical biochemistry
  • Clinical chemistry analysis
  • Reagents, clips, and cartridges
  • Analyzers
  • Glucose monitoring
  • Blood glucose strips
  • Glucose monitors
  • Urine glucose strips
  • Blood gas electrolyte analysis
  • Reagents, clips, and cartridges
  • Blood gas & electrolyte analyzers
• Immunodiagnostics
  • Lateral flow assays
  • Rapid tests
  • Strip readers (Lateral flow readers)
  • Elisa tests
  • Allergen-specific immunodiagnostic tests
  • Immunoassay analyzers
  • Other immunodiagnostic Animal Types
• Hematology
  • Cartridges
  • Analyzers
• Urinalysis
  • Clips & cartridges/panels
  • Urine Analyzers
  • Urine test strips
• Molecular diagnostics
  • Polymerase chain reaction tests
  • Microarrays
  • Other molecular diagnostic Animal Types
• Other Companion Animal Diagnostic Technologies

Global Companion Animal Diagnostics Market Size by Animal Type & CAGR (2024-2031)

• Market Overview
• Dogs
• Cats
• Horses
• Other companion animals

Global Companion Animal Diagnostics Market Size by Application & CAGR (2024-2031)

• Market Overview
• Clinical Pathology
• Bacteriology
• Virology
• Parasitology
• Other Applications

Global Companion Animal Diagnostics Market Size by End User & CAGR (2024-2031)

• Market Overview
• Diagnostic Laboratories
• Veterinary Hospitals & Clinics
• Research Institutes & Universities
• Home-care Settings

Global Companion Animal Diagnostics Market Size & CAGR (2024-2031)

• North America (Technology, Animal Type, Application, End User)
  • US
  • Canada
• Europe (Technology, Animal Type, Application, End User)
  • UK
  • Germany
  • Spain
  • France
  • Italy
  • Rest of Europe
• Asia-Pacific (Technology, Animal Type, Application, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia Pacific
• Latin America (Technology, Animal Type, Application, End User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Technology, Animal Type, Application, End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2023
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2023
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2021-2023)

Key Company Profiles

• Idexx Laboratories, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Zoetis Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Thermo Fisher Scientific Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Biomerieux SA
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Virbac
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Neogen Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Fujifilm Holdings Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Indical Bioscience GmbH
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Idvet
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Randox Laboratories, Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bionote, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Skyla Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Urit Medical Electronic Co., Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Nova Biomedical
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Fassisi GmbH
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Swissavans AG
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Alvedia
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Megacor Veterinary Diagnostics
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Biopanda Reagents Ltd
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Anipoc Ltd
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Ring Biotechnology Co Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendation